INFIBEAM continues its journey of segregation
M & A Critique|November 2023
Recently, the management of Infibeam Avenues Limited announced internal restructuring which will pave the way for separate listing of its Global Top Level Domain business and will carve out immovable property at Gift City into a separate wholly owned subsidiary.
INFIBEAM continues its journey of segregation

Infibeam Avenues Limited ("Infibeam" or "Demerged Company" or "Transferor Company") is engaged in business of digital payment, E-Commerce services, comprehensive suite of web services spanning digital payment solution, data centre infrastructure, software platform etc. The equity shares of Infibeam are listed on nationwide bourses.

Odigma Consultancy Solutions Limited ("ODIGMA" or "Resulting Company") is a wholly owned subsidiary of Infibeam engaged in activities relating to e-commerce.

Infibeam Projects Management Private Limited ("IPMPL" or "Transferee Company") is a wholly owned subsidiary of Infibeam.

The Proposed Transaction:

Board of Directors of Infibeam Avenues Limited ("Infibeam" or "Demerged Company" or "Transferor Company"), at its meeting has considered and approved a Composite Scheme of Arrangement between the Company, Odigma Consultancy Solutions Limited ("ODIGMA" or "Resulting Company") and Infibeam Projects Management Private Limited ("IPMPL" or "Transferee Company") and their respective shareholders and creditors ("Scheme") under Sections 230 to 232 read with Section 66 of the Companies Act, 2013 ("Act") and other applicable laws including the rules and regulations which inter-alia provides for

i. The demerger, transfer and vesting of Global Top-Level Domain ("GTLD") Undertaking from the Company to the Resulting Company on a going concern basis;

ii. transfer and vesting of the Project Management Undertaking of the Company, as a going concern on Slump Sale basis, to the Transferee Company;

The Appointed date for the transaction is 1st April 2023.

Demerger

Diese Geschichte stammt aus der November 2023-Ausgabe von M & A Critique.

Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.

Diese Geschichte stammt aus der November 2023-Ausgabe von M & A Critique.

Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.

WEITERE ARTIKEL AUS M & A CRITIQUEAlle anzeigen
Batliboi Ltd. merging its associate company
M & A Critique

Batliboi Ltd. merging its associate company

Batliboi Limited has a history of collaborations with various foreign technical partners and has subsidiaries like Hydraulic & General Engineers Ltd. and Batliboi International Ltd. In March 2024, the board of Directors of Batliboi Limited accorded their approval for the merger of promoter owned private company with itself.

time-read
2 Minuten  |
May 2024
TVS Motors issuances of convertible preference shares as bonus instead of dividend
M & A Critique

TVS Motors issuances of convertible preference shares as bonus instead of dividend

Recently, well known auto manufacturer announced the issuance of preference shares as a bonus to all equity shareholders.

time-read
3 Minuten  |
May 2024
Aditya Birla Fashion & Retails Scheme to undo its consolidation
M & A Critique

Aditya Birla Fashion & Retails Scheme to undo its consolidation

Corporate restructuring saga continues for Aditya Birla Group.

time-read
5 Minuten  |
May 2024
Advent International to combine its listed & private entity business
M & A Critique

Advent International to combine its listed & private entity business

Recently, Advent International announced the merger of its privately held pharma company into recently acquired listed pharma company.

time-read
6 Minuten  |
April 2024
Eris Lifesciences on Acquisition Spree to expand its branded formulations portfolio
M & A Critique

Eris Lifesciences on Acquisition Spree to expand its branded formulations portfolio

Recently, Eris Lifesciences Limited announced acquisition of 'branded Formulation Business' of Biocon Biologics Limited pertaining to the India territory through slump sale. In addition, ELL also announced a foreign acquisition.

time-read
7 Minuten  |
April 2024
Vuenow Merges All Entities Will It Create Value?
M & A Critique

Vuenow Merges All Entities Will It Create Value?

Recently, Vuenow Infratech Limited, a BSE listed company, announced the merger of two private companies itself.

time-read
6 Minuten  |
April 2024
Dalmia Group continues its journey of segregation of businesses by way of demerger
M & A Critique

Dalmia Group continues its journey of segregation of businesses by way of demerger

Recently Dalmia Group announced yet another restructuring of one of its group companies Dalmia Bharat Refractories Limited.

time-read
6 Minuten  |
March 2024
Rane Group to consolidate its listed operational entities
M & A Critique

Rane Group to consolidate its listed operational entities

After keeping different operational listed entities for years, Rane Group, one of the key players in Auto Ancillary space has decided to consolidate its listed operational companies under Rane (Madras) Limited.

time-read
3 Minuten  |
March 2024
Zuari Group's attempts to create the biggest private producer of Fertilisers
M & A Critique

Zuari Group's attempts to create the biggest private producer of Fertilisers

“Transfer of Identified shares from ZACL to ZMPPL is a precondition for approval of the merger transaction”

time-read
7 Minuten  |
March 2024
Shankara Building Products separates its trading & marketplace business for independent growth
M & A Critique

Shankara Building Products separates its trading & marketplace business for independent growth

Recently, Shankara Building Products Limited announced the demerger of its trading/building material marketplace business from its manufacturing business.

time-read
4 Minuten  |
February 2024